Phospholipid formulations
US6214375A · kind A · utility
132Cited by
11References
7Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 29, 1999 |
| Grant date | Apr 10, 2001 |
| Priority date | — |
| Expiry date | Mar 29, 2019 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A liposome pharmaceutical composition is provided. The liposomes are comprised of a medicinally active agent, at least three phospholipids and at least two biodegradable polymers. The liposomes can be used for delivery of various cosmetics and drugs, and can be administered orally, topically or by injection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.